TOP1 and Hyperkalemia: On the other hand, a risk of death outcome greater than 10% was found for antipropulsives, coxibs, drugs for treatment of hyperkalemia and hyperphosphatemia, oral bowel cleanser, other antineoplastic agents, and TOP1 inhibitors.